News Chart Harmony Biosciences Holdings, Inc.

Equities

HRMY

US4131971040

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-12 pm EST			5-day change	1st Jan Change
38.27 ^USD	-0.73%		+4.14%	+2.27%

Jan. 12	Harmony Biosciences guides to over $1 billion in Wakix® revenue in 2026 advancing robust late-stage pipeline with potential for long-term value creation	RE
Dec. 16	Harmony Biosciences, Beacon Biosignals Collaborate on Phase 3 Trials in Narcolepsy, Hypersomnia	MT

238856336a6d9d5db69d681bdde.-r_9dAWH4vY1srhFCV64Tbt6eq69Gvn2Rt1cJozmm6s.iM6fFU7Dps5g_vZzcGz5CNwXTPfKcpiycJMvF9qc68qL7pAcM8Gyp3zxiA~b36f18c72db4e66d5ef1b1f58a90cd31